Protective effectiveness of hantavirus vaccine

Emerging Infectious Diseases

Volumn 10, Issue 12, 2004, Pages 2218-2220

  Park, Keeho ^a   Kim, Chang Soo ^b   Moon, Ki Tae ^c  

^a National Cancer Center   (South Korea)

^b Republic of Korea Army Headquarters   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HANTAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFICACY; HANTAVIRUS; HUMAN; MAJOR CLINICAL STUDY; PROTECTION; SOUTH KOREA; VIRUS HEMORRHAGIC FEVER;

EID: 9744230575     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1012.040684     Document Type: Article

References (9)

1. Lee HW, Ahn CN, Song JW, Back LJ, Seo TJ, Park SC. Field trial of an inactivated vaccine against hemorrhagic fever with renal syndrome in humans. Arch Virol. 1990;1(Suppl):35-47.
2. Cho HW, Howard CR. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine. 1999;17:2569-75.
3. ò): consideration of active immunization in South Korea. Yonsei Med J. 2001;42:278-84.
4. Cho H-W, Howard CR, Lee H-W. Review of an inactivated vaccine against hantaviruses. Intervirology. 2002;45:328-33.
5. Takeuchi T, Yamamoto T, Itoh M, Tsukada K, Yasue N, Lee HW. Clinical studies on hemorrhagic fever with renal syndrome found in Nagoya City University Medical School. Kidney Int Suppl. 1991;35(Suppl):S84-7.
6. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
7. Henderson RH. Vaccination: successes and challenges. In: Cutts FT, editor. Vaccination and world health. Chichester (UK): John Wiley and Sons; 1994. p. 5.
8. Lee HW, Chu YK, Woo YD, An CN, Kim H, Tkachenko E, et al. Vaccines against hemorrhagic fever with renal syndrome. In: Saluzzo JF, Dodet B, editors. Factors in the emergence and control of rodent-borne viral diseases (Hantaviral and Arenaviral diseases). Amsterdam: Elsevier; 1999. p. 147-56.
9. Harrison LH, Broome CV, Hightower AW, Hoppe CC, Makintubee S, Sitze SL, et al. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. JAMA. 1988;260:1413-8.